Novel p27^kip1 C-Terminal Scatter Domain Mediates Rac-Dependent Cell Migration Independent of Cell Cycle Arrest Functions

REFERENCES

• Albrecht, J. H., B. M. Rieland, C. J. Nelsen, and C. L. Ahonen. 1999. Regulation of G(1) cyclin-dependent kinases in the liver: role of nuclear localization and p27 sequestration. Am. J. Physiol. 277: G1207–G1216.
   PubMedGoogle Scholar
• Becker-Hapak, M., S. S. McAllister, and S. F. Dowdy. 2001. TAT-mediated protein transduction into mammalian cells. Methods 24: 247–256.
   PubMed Web of Science ®Google Scholar
• Blain, S. W., E. Montalvo, and J. Massague. 1997. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J. Biol. Chem. 272: 25863–25872.
   PubMed Web of Science ®Google Scholar
• Butty, A. C., P. M. Pryciak, L. S. Huang, I. Herskowitz, and M. Peter. 1998. The role of Far1p in linking the heterotrimeric G protein to polarity establishment proteins during yeast mating. Science 282: 1511–1516.
   PubMed Web of Science ®Google Scholar
• Carrano, A. C., E. Eytan, A. Hershko, and M. Pagano. 1999. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1: 193–199.
   PubMed Web of Science ®Google Scholar
• Chellaiah, M. A., N. Soga, S. Swanson, S. McAllister, U. Alvarez, D. Wang, S. F. Dowdy, and K. A. Hruska. 2000. Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J. Biol. Chem. 275: 11993–12002.
   PubMedGoogle Scholar
• Ciaparrone, M., H. Yamamoto, Y. Yao, A. Sgambato, G. Cattoretti, N. Tomita, T. Monden, H. Rotterdam, and I. B. Weinstein. 1998. Localization and expression of p27KIP1 in multistage colorectal carcinogenesis. Cancer Res. 58: 114–122.
   PubMed Web of Science ®Google Scholar
• Ciarallo, S., V. Subramaniam, W. Hung, J.-H. Lee, R. Kotchetkov, C. Sandhu, A. Milic, and J. M. Slingerland. 2002. Altered p27Kip1 phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor β-mediated G1 arrest. Mol. Cell. Biol. 22: 2993–3002.
   PubMedGoogle Scholar
• Clurman, B. E., and P. Porter. 1998. New insights into the tumor suppression function of P27(kip1). Proc. Natl. Acad. Sci. USA 95: 15158–15160.
   PubMedGoogle Scholar
• Comoglio, P. M., and C. Boccaccio. 2001. Scatter factors and invasive growth. Semin. Cancer Biol. 11: 153–165.
   PubMedGoogle Scholar
• Doki, Y., M. Imoto, E. K. Han, A. Sgambato, and I. B. Weinstein. 1997. Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1. Carcinogenesis 18: 1139–1148.
   PubMedGoogle Scholar
• Ekholm, S. V., and S. I. Reed. 2000. Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr. Opin. Cell Biol. 12: 676–684.
   PubMed Web of Science ®Google Scholar
• Ezhevsky, S. A., H. Nagahara, A. M. Vocero-Akbani, D. R. Gius, M. C. Wei, and S. F. Dowdy. 1997. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb. Proc. Natl. Acad. Sci. USA 94: 10699–10704.
   PubMed Web of Science ®Google Scholar
• Fredersdorf, S., J. Burns, A. M. Milne, G. Packham, L. Fallis, C. E. Gillett, J. A. Royds, D. Peston, P. A. Hall, A. M. Hanby, D. M. Barnes, S. Shousha, M. J. O'Hare, and X. Lu. 1997. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc. Natl. Acad. Sci. USA 94: 6380–6385.
   PubMed Web of Science ®Google Scholar
• Ganoth, D., G. Bornstein, T. K. Ko, B. Larsen, M. Tyers, M. Pagano, and A. Hershko. 2001. The cell-cycle regulatory protein Cks1 is required for SCFSkp2-mediated ubiquitinylation of p27. Nat. Cell Biol. 3: 321–324.
   PubMed Web of Science ®Google Scholar
• Groth, A., J. D. Weber, B. M. Willumsen, C. J. Sherr, and M. F. Roussel. 2000. Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases. J. Biol. Chem. 275: 27473–27480.
   PubMedGoogle Scholar
• Hall, A. 1998. Rho GTPases and the actin cytoskeleton. Science 279: 509–514.
   PubMed Web of Science ®Google Scholar
• Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100: 57–70.
   PubMed Web of Science ®Google Scholar
• Hengst, L., and S. I. Reed. 1998. Inhibitors of the Cip/Kip family. Curr. Top. Microbiol. Immunol. 227: 25–41.
   PubMedGoogle Scholar
• Hordijk, P. L., J. P. ten Klooster, R. A. van der Kammen, F. Michiels, L. C. Oomen, and J. G. Collard. 1997. Inhibition of invasion of epithelial cells by Tiam1-Rac signaling. Science 278: 1464–1466.
   PubMed Web of Science ®Google Scholar
• Ishida, N., T. Hara, T. Kamura, M. Yoshida, K. Nakayama, and K. I. Nakayama. 2002. Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J. Biol. Chem. 277: 14355–14358.
   PubMed Web of Science ®Google Scholar
• Ishida, N., M. Kitagawa, S. Hatakeyama, and K. Nakayama. 2000. Phosphorylation at serine 10, a major phosphorylation site of p27Kip1, increases its protein stability. J. Biol. Chem. 275: 25146–25154.
   PubMed Web of Science ®Google Scholar
• Jeffers, M., S. Rong, and G. F. Vande Woude. 1996. Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis. J. Mol. Med. 74: 505–513.
   PubMed Web of Science ®Google Scholar
• Jiang, W., S. Hiscox, K. Matsumoto, and T. Nakamura. 1999. Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit. Rev. Oncol. Hematol. 29: 209–248.
   PubMed Web of Science ®Google Scholar
• Kouvaraki, M., V. G. Gorgoulis, G. Z. Rassidakis, P. Liodis, C. Markopoulos, J. Gogas, and C. Kittas. 2002. High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas. Cancer 94: 2454–2465.
   PubMedGoogle Scholar
• Luo, Y., J. Hurwitz, and J. Massague. 1995. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 375: 159–161.
   PubMed Web of Science ®Google Scholar
• Malek, N. P., H. Sundberg, S. McGrew, K. Nakayama, T. R. Kyriakidis, and J. M. Roberts. 2001. A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase. Nature 413: 323–327.
   PubMedGoogle Scholar
• Nagahara, H., A. M. Vocero-Akbani, E. L. Snyder, A. Ho, D. G. Latham, N. A. Lissy, M. Becker-Hapak, S. A. Ezhevsky, and S. F. Dowdy. 1998. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat. Med. 4: 1449–1452.
   PubMed Web of Science ®Google Scholar
• Nobes, C. D., and A. Hall. 1995. Rho, rac and cdc42 GTPases: regulators of actin structures, cell adhesion and motility. Biochem. Soc. Trans. 23: 456–459.
   PubMed Web of Science ®Google Scholar
• Orend, G., T. Hunter, and E. Ruoslahti. 1998. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Oncogene 16: 2575–2583.
   PubMedGoogle Scholar
• Piva, R., I. Cancelli, P. Cavalla, S. Bortolotto, J. Dominguez, G. F. Draetta, and D. Schiffer. 1999. Proteasome-dependent degradation of p27/kip1 in gliomas. J. Neuropathol. Exp. Neurol. 58: 691–696.
   PubMed Web of Science ®Google Scholar
• Pollard, T. D., L. Blanchoin, and R. D. Mullins. 2001. Actin dynamics. J. Cell Sci. 114: 3–4.
   PubMedGoogle Scholar
• Polyak, K., M. H. Lee, H. Erdjument-Bromage, A. Koff, J. M. Roberts, P. Tempst, and J. Massague. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59–66.
   PubMed Web of Science ®Google Scholar
• Potempa, S., and A. J. Ridley. 1998. Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. Mol. Biol. Cell 9: 2185–2200.
   PubMed Web of Science ®Google Scholar
• Pruyne, D., and A. Bretscher. 2000. Polarization of cell growth in yeast. J. Cell Sci. 113: 571–585.
   PubMed Web of Science ®Google Scholar
• Pruyne, D., and A. Bretscher. 2000. Polarization of cell growth in yeast. I. Establishment and maintenance of polarity states. J. Cell Sci. 113: 365–375.
   PubMed Web of Science ®Google Scholar
• Reynisdottir, I., and J. Massague. 1997. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev. 11: 492–503.
   PubMed Web of Science ®Google Scholar
• Ridley, A. J., W. E. Allen, M. Peppelenbosch, and G. E. Jones. 1999. Rho family proteins and cell migration. Biochem. Soc. Symp. 65: 111–123.
   PubMedGoogle Scholar
• Ridley, A. J., P. M. Comoglio, and A. Hall. 1995. Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells. Mol. Cell. Biol. 15: 1110–1122.
   PubMed Web of Science ®Google Scholar
• Rodier, G., A. Montagnoli, L. Di Marcotullio, P. Coulombe, G. F. Draetta, M. Pagano, and S. Meloche. 2001. p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J. 20: 6672–6682.
   PubMed Web of Science ®Google Scholar
• Rong, S., S. Segal, M. Anver, J. H. Resau, and G. F. Vande Woude. 1994. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc. Natl. Acad. Sci. USA 91: 4731–4735.
   PubMed Web of Science ®Google Scholar
• Royal, I., and M. Park. 1995. Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase. J. Biol. Chem. 270: 27780–27787.
   PubMedGoogle Scholar
• Sánchez-Beato, M., F. I. Camacho, J. C. Martínez-Montero, A. I. Sáez, R. Villuendas, L. Sánchez-Verde, J. F. García, and M. A. Piris. 1999. Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells. Blood 94: 765–772.
   PubMed Web of Science ®Google Scholar
• Schaper, F., E. Siewert, M. J. Gomez-Lechon, P. Gatsios, M. Sachs, W. Birchmeier, P. C. Heinrich, and J. Castell. 1997. Hepatocyte growth factor/scatter factor (HGF/SF) signals via the STAT3/APRF transcription factor in human hepatoma cells and hepatocytes. FEBS Lett. 405: 99–103.
   PubMed Web of Science ®Google Scholar
• Sgambato, A., Y. J. Zhang, N. Arber, H. Hibshoosh, Y. Doki, M. Ciaparrone, R. M. Santella, A. Cittadini, and I. B. Weinstein. 1997. Deregulated expression of p27(Kip1) in human breast cancers. Clin. Cancer Res. 3: 1879–1887.
   PubMedGoogle Scholar
• Sherr, C. J., and J. M. Roberts. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13: 1501–1512.
   PubMed Web of Science ®Google Scholar
• Slingerland, J., and M. Pagano. 2000. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J. Cell. Physiol. 183: 10–17.
   PubMed Web of Science ®Google Scholar
• Spruck, C., H. Strohmaier, M. Watson, A. P. Smith, A. Ryan, T. W. Krek, and S. I. Reed. 2001. A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1. Mol. Cell 7: 639–650.
   PubMed Web of Science ®Google Scholar
• Stella, M. C., and P. M. Comoglio. 1999. HGF: a multifunctional growth factor controlling cell scattering. Int. J. Biochem. Cell Biol. 31: 1357–1362.
   PubMed Web of Science ®Google Scholar
• Stoker, M., E. Gherardi, M. Perryman, and J. Gray. 1987. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327: 239–242.
   PubMed Web of Science ®Google Scholar
• Stuart, K. A., S. M. Riordan, S. Lidder, L. Crostella, R. Williams, and G. G. Skouteris. 2000. Hepatocyte growth factor/scatter factor-induced intracellular signalling. Int. J. Exp. Pathol. 81: 17–30.
   PubMed Web of Science ®Google Scholar
• Takaishi, K., T. Sasaki, H. Kotani, H. Nishioka, and Y. Takai. 1997. Regulation of cell-cell adhesion by rac and rho small G proteins in MDCK cells. J. Cell Biol. 139: 1047–1059.
   PubMed Web of Science ®Google Scholar
• Tomoda, K., Y. Kubota, and J. Kato. 1999. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398: 160–165.
   PubMed Web of Science ®Google Scholar
• Tsuboi, K., S. Yamaoka, M. Maki, G. Ohshio, T. Tobe, and M. Hatanaka. 1990. Soluble factors including proteinases released from damaged cells may trigger the wound healing process. Biochem. Biophys. Res. Commun. 168: 1163–1170.
   PubMedGoogle Scholar
• Wadia, J. S., and S. F. Dowdy. 2002. Protein transduction technology. Curr. Opin. Biotechnol. 13: 52–56.
   PubMed Web of Science ®Google Scholar
• Wang, G., R. Miskimins, and W. K. Miskimins. 1999. The cyclin-dependent kinase inhibitor p27Kip1 is localized to the cytosol in Swiss/3T3 cells. Oncogene 18: 5204–5210.
   PubMedGoogle Scholar
• Weinstein, I. B. 2000. Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis. Carcinogenesis 21: 857–864.
   PubMed Web of Science ®Google Scholar
• Xu, M., K.-A. Sheppard, C.-Y. Peng, A. S. Yee, and H. Piwnica-Worms. 1994. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol. Cell. Biol. 14: 8420–8431.
   PubMed Web of Science ®Google Scholar